Treatment involving oral steroids for a period of two years or more could be used to minimize the risk of rheumatoid arthritis (RA) related lymphoma, as per data presented at EULAR 2007, the Annual European Congress of Rheumatology, in Barcelona, Spain.
It was reported that benefits of steroids were noticed irrespective of when in the course [...]
August 19, 2010 | Posted in
Steroids Blog |
Read More »
Women suffering from rheumatoid arthritis (RA) can find significant relief coming their way with CH-1504, a potential oral drug for RA. Treatment with this drug is easier when compared to presently available treatment options.
A pharmaceutical company specializing in treatment for rheumatoid arthritis and other immunological diseases, Chelsea Therapeutics, is presently developing an oral anti-inflammatory [...]
July 11, 2010 | Posted in
Steroids Blog |
Read More »
Researchers have been able to identify a potential option for treating asthma, as per a small study in Thorax. This treatment option is concerned with treating severe form of asthma by blocking a powerful immune system chemical that is present in large quantities in asthmatic patients.
Severe asthma is rare as one in [...]
June 15, 2010 | Posted in
Steroids Blog |
Read More »
CH-1504, a potential oral drug for rheumatoid arthritis (RA), can help women to treat their condition earlier because it is less arduous than the currently available treatment forms.
Chelsea Therapeutics, a pharmaceutical company specializing in treatment for RA and other immunological diseases, is currently developing an oral anti-inflammatory medication and conducting Phase [...]
May 13, 2010 | Posted in
Steroids Blog |
Read More »
Women are at a higher risk of osteoporosis-associated fractures but still most of them are unaware of this condition, according to a serious international public health concern that was raised by researchers after results from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
The study also suggested that there is a [...]
May 4, 2010 | Posted in
Steroids Blog |
Read More »
Rituxan, a drug previously approved for the treatment of non-Hodgkin’s B cell lymphoma and rheumatoid arthritis, has been identified by researchers to be an effective option for treating severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy.
The news was presented on October 18 at the annual meeting of the American College of Rheumatology [...]
April 23, 2010 | Posted in
Steroids Blog |
Read More »
The risk of rheumatoid arthritis (RA) related lymphoma is reduced to a significant extent when oral steroids are used for a period of two or more years, as per a recent study.
Furthermore, these positive effects were noticed regardless of when in the course of the disease the steroids were initially administered. It was, however, disclosed [...]
April 7, 2010 | Posted in
Steroids Blog |
Read More »
Harris Perlman, a researcher from Northwestern University Feinberg School of Medicine, has invented a novel way to halt and even reverse rheumatoid arthritis.
This way was developed by imitation of a suicide molecule (whimsically referred to as Casper the Ghost) that floats undetected into overactive immune cells responsible for the disease.
From Sciencedaily.com:
Current treatments for rheumatoid arthritis [...]
February 25, 2010 | Posted in
Steroids Blog |
Read More »
An oral anti-inflammatory medication for treating patients suffering from rheumatoid arthritis (RA) is under development stage with efforts from Chelsea Therapeutics, a pharmaceutical company specializing in treatment for RA and other immunological disease.
The research is presently in the Phase I clinical trials in the U.K. This drug is believed to help women to treat their [...]
February 5, 2010 | Posted in
Steroids Blog |
Read More »
According to news presented on October 18 at the annual meeting of the American College of Rheumatology in Philadelphia, a drug that was previously approved for treating non-Hodgkin’s B cell lymphoma and rheumatoid arthritis has been hailed as effective for treating severe ANCA-associated vasculitis as effectively as cyclophosphamide, the present standard therapy.
The drug, Rituxan, can [...]
January 28, 2010 | Posted in
Steroids Blog |
Read More »
